Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)
Indian Council of Medical Research · National Institute of Epidemiology · +1 more institution
Indexed incrossrefpubmed
Abstract
Objective
To investigate the effectiveness of using convalescent plasma to treat moderate coronavirus disease 2019 (covid-19) in adults in India.
Design
Open label, parallel arm, phase II, multicentre, randomised controlled trial.
Citation impact
732
total citations
- FWCI
- 17.45
- Percentile
- 100%
- References
- 26
Citations per year
Authors
6- AAAnup AgarwalCorresponding
Indian Council of Medical Research
- AMAparna Mukherjee
Indian Council of Medical Research
- GKGunjan Kumar
Indian Council of Medical Research
- PCPranab Chatterjee
Indian Council of Medical Research
- TBTarun Bhatnagar
Indian Council of Medical Research, National Institute of Epidemiology
Topics & keywords
Topics
Keywords
- Medicine
- Confidence interval
- Fraction of inspired oxygen
- Randomized controlled trial
- Internal medicine
- Blood pressure
- Surgery
- Mechanical ventilation
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.